Angiotensin II type-1 receptor blockers enhance the effects of bevacizumab-based chemotherapy in metastatic colorectal cancer patients

By            

Molecular and Clinical Oncology, Vol. 3, Iss. 6, 2015-01 ,pp. : 1295-1300

Science Publishers

Access to resources Recommend Favorite

Potential Deployment of Angiotensin I Converting Enzyme Inhibitors and of Angiotensin II Type 1 and Type 2 Receptor Blockers in Cancer Chemotherapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 6, Iss. 5, 2006-09 ,pp. : 451-460

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy

By Wilop Stefan   Hobe Sabine   Crysandt Martina   Esser Albert   Osieka Rainhardt   Jost Edgar  

Journal of Cancer Research and Clinical Oncology, Vol. 135, Iss. 10, 2009-10 ,pp. : 1429-1435

Springer Publishing Company

Access to resources Recommend Favorite

Effect of lipopolysaccharide on angiotensin II type 1 receptor expression and function in human pulmonary microvascular endothelial cells

By      

Molecular Medicine Reports, Vol. 12, Iss. 6, 2015-01 ,pp. : 8289-8293

Spandidos Publications

Access to resources Recommend Favorite

Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker

By Molteni A.   Moulder J. E.   Cohen E. F.   Ward W. F.   Fish B. L.   Taylor J. M.   Wolfe L. F.   Brizio-Molteni L.   Veno P.  

International Journal of Radiation Biology, Vol. 76, Iss. 4, 2000-04 ,pp. : 523-532

Informa Healthcare

Access to resources Recommend Favorite